OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares
$5,63
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 10, 2026
Zakres 52 tyg.
$2–$6
96% of range
Ocena Analityków
BUY
13 analysts
Cena Docelowa
$12
+119% upside
P/E (TTM)
-5.1
ROE
-195.7%
Marża Zysku Netto
-157.4%
OBIO Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$5.63
Kapitalizacja Rynkowa
$321M
P/E (TTM)
-5.1
EPS (TTM)
$-1.11
Przychody (TTM)
$33M
Stopa dywidendy
—
ROE
-195.7%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $6
OBIO Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$33M
2022-12-31
→
2025-12-31
EPS
$-1.11
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-49M
2023-12-31
→
2025-12-31
Marże
-157.4%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
OBIO
Mediana porównawcza
P/E (TTM)
-5.1
27.5
P/S (TTM)
9.6
6.8
P/B
6.0
3.7
Price / FCF (Cena / FCF)
-6.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
OBIO
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-154.7%
—
Net Profit Margin (Marża Zysku Netto)
-157.4%
-46.8%
ROA
-55.2%
-31.4%
ROE
-195.7%
-59.1%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
OBIO
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
6.4
4.6
Quick Ratio (Wskaźnik Szybkości)
6.4
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
OBIO
Mediana porównawcza
Revenue YoY (Przychody R/R)
1169.2%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
111.6%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
OBIO
Mediana porównawcza
OBIO Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
13 analityków
- Mocne kupno 3 23,1%
- Kup 8 61,5%
- Trzymaj 2 15,4%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-08-15
Mediana
$10.00
Średnia
$12.33
← Poniżej wszystkich celów
$5.63
Niski
$9.00
Wysoki
$20.00
Średni cel
$10.00
+77,6%
Średnia cel
$12.33
+119,0%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.07%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.38 | $-0.40 | 0.02% |
| 31 marca 2026 | $-0.33 | $-0.44 | 0.11% |
| 31 grudnia 2025 | $-0.13 | $-0.39 | 0.26% |
| 30 września 2025 | $-0.40 | $-0.44 | 0.04% |
| 30 czerwca 2025 | $-0.50 | $-0.51 | 0.01% |
| 31 marca 2025 | $-0.49 | $-0.49 | 0.00% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | — |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| TMCI | — | -2.6 | 1.6% | -27.7% | -63.8% | 79.8% |
| STIM | $95M | -2.3 | 99.2% | -26.2% | -155.7% | 48.5% |
| PDEX | $142M | 16.3 | 23.7% | 13.5% | 26.2% | 29.3% |
| LUCD | $143M | -1.1 | 8.3% | -1232.7% | -617.2% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $33M | $3M | $3M | $4M | |
| Cost of Revenue | $190.0K | $204.0K | $186.0K | $211.0K | |
| R&D Expense | $58M | $43M | $34M | $22M | |
| SG&A Expense | $27M | $24M | $20M | $14M | |
| Operating Expenses | $85M | $67M | $54M | $36M | |
| Operating Income | $-52M | $-64M | $-52M | $-33M | |
| Interest Income | · | · | · | $345.1K | |
| Other Non-op | · | $-11.0K | · | · | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-53M | $-61M | $-49M | $-34M | |
| EPS (Basic) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| EPS (Diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| Shares (Basic) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| Shares (Diluted) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| EBITDA | $-51M | $-64M | $-51M | $-3M |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $22M | $31M | $20M | |
| Short-term Investments | $72M | $45M | $57M | $64M | |
| Receivables | $95.0K | $92.0K | $99.0K | $96.0K | |
| Inventory | $310.0K | $173.0K | $146.0K | $276.0K | |
| Prepaid Expense | $994.0K | $2M | $1M | $533.0K | |
| Current Assets | $108M | $69M | $89M | $85M | |
| PP&E (Net) | $2M | $1M | $1M | $1M | |
| PP&E (Gross) | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $778.0K | |
| Total Assets | $115M | $76M | $95M | $96M | |
| Accounts Payable | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $10M | $6M | $5M | $5M | |
| Current Liabilities | $17M | $16M | $11M | $19M | |
| Capital Leases | $936.0K | $2M | $1M | $2M | |
| Deferred Tax | $393.0K | $561.0K | $508.0K | $637.0K | |
| Other Non-current Liabilities | $308.0K | $40.0K | · | $196.0K | |
| Total Liabilities | $51M | $43M | $27M | $43M | |
| Long-term Debt | $15M | $15M | · | · | |
| Common Stock | $6.0K | $4.0K | $4.0K | $2.0K | |
| Paid-in Capital | $416M | $343M | $317M | $252M | |
| Retained Earnings | $-363M | $-310M | $-249M | $-200M | |
| AOCI | $60.0K | $52.0K | $-10.0K | $-8.0K | |
| Stockholders' Equity | $54M | $33M | $68M | $53M | |
| Liabilities + Equity | $115M | $76M | $95M | $96M | |
| Shares Outstanding | 57,032,963 | 38,194,442 | 35,777,412 | 20,187,850 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $327.0K | $308.0K | $287.0K | $222.0K | |
| Stock-based Comp | $12M | $11M | $8M | $3M | |
| Other Non-cash | $-9M | $-457.0K | $-5M | · | |
| Operating Cash Flow | $-49M | $-51M | $-46M | $-29M | |
| CapEx | $489.0K | $289.0K | $78.0K | $591.0K | |
| Investing Cash Flow | $-27M | $13M | $11M | $-64M | |
| Net Debt Issued | · | · | $-11M | · | |
| Financing Cash Flow | $88M | $29M | $46M | $103M | |
| Net Change in Cash | $12M | $-8M | $11M | $10M | |
| Free Cash Flow | $-49M | $-51M | $-46M | · |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -154.7% | -2437.5% | -1866.2% | · | |
| Net Margin | -157.4% | -2313.3% | -1779.7% | · | |
| EBITDA Margin | -153.8% | -2425.8% | -1855.8% | · | |
| ROA | -55.2% | -71.2% | -51.5% | -2.4% | |
| ROE | -195.7% | -154.2% | -66.5% | -10.0% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 6.4 | 4.3 | 8.0 | 0.2 | |
| Quick Ratio | 6.4 | 4.1 | 7.8 | 0.1 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.8 | 1.3 | 0.9 | · | |
| Receivables Turnover | 358.1 | 27.6 | 28.3 | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 1169.2% | -4.4% | -21.9% | · | |
| Revenue CAGR 3Y | 111.6% | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $33M | $3M | $3M | $4M | |
| Net Income TTM | $-53M | $-61M | $-49M | $-34M | |
| Market Cap | $237M | $153M | $327M | $44M | |
| P/E | -3.7 | -2.4 | -6.2 | -4.5 | |
| P/S | 7.1 | 57.9 | 118.4 | 12.6 | |
| P/B | 4.4 | 4.6 | 4.8 | -6.4 | |
| P / Tangible Book | 4.4 | 4.6 | 4.8 | 0.8 | |
| P / Cash Flow | -4.8 | -3.0 | -7.1 | -28.1 | |
| P / FCF | -4.8 | -3.0 | -7.1 | · | |
| Earnings Yield | -26.8% | -41.5% | -16.2% | -22.4% |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0K | $110.0K | $31M | $861.0K | $836.0K | $868.0K | $253.0K | $987.0K | $778.0K | $620.0K | $262.0K | $419.0K | $915.0K | $1M | $1M | $1M | |
| Cost of Revenue | $25.0K | $32.0K | $51.0K | $49.0K | $46.0K | $44.0K | $58.0K | $68.0K | $44.0K | $34.0K | $47.0K | $41.0K | $54.0K | $44.0K | $53.0K | $56.0K | |
| R&D Expense | $17M | $16M | $17M | $14M | $14M | $13M | $11M | $12M | $11M | $9M | $9M | $9M | $8M | $8M | $8M | $6M | |
| SG&A Expense | $6M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $4M | $3M | $5M | |
| Operating Expenses | $22M | $22M | $24M | $21M | $20M | $20M | $17M | $17M | $18M | $15M | $13M | $15M | $14M | $13M | $11M | $11M | |
| Operating Income | $-22M | $-22M | $7M | $-20M | $-19M | $-19M | $-17M | $-16M | $-17M | $-14M | $-12M | $-15M | $-13M | $-12M | $-10M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $351.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $-11.0K | · | · | · | · | · | · | |
| Net Income | $-24M | $-21M | $6M | $-21M | $-19M | $-19M | $-16M | $-15M | $-16M | $-13M | $-13M | $-13M | $-12M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| EPS (Diluted) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| Shares (Basic) | 63,812,098 | 62,721,869 | -81,067,550 | 52,186,503 | 38,392,716 | 38,235,409 | -72,378,603 | 37,621,495 | 35,800,273 | 35,777,877 | -64,275,386 | 35,243,598 | 34,613,466 | 27,643,549 | -24,562,416 | 20,187,773 | |
| Shares (Diluted) | 63,812,098 | 62,721,869 | -81,067,550 | 52,186,503 | 38,392,716 | 38,235,409 | -72,378,603 | 37,621,495 | 35,800,273 | 35,777,877 | -64,275,386 | 35,243,598 | 34,613,466 | 27,643,549 | -24,562,416 | 20,187,773 | |
| EBITDA | $-22M | $-22M | · | $-20M | $-19M | $-19M | · | $-16M | $-17M | $-14M | · | $-15M | $-13M | $-11M | · | $-813.4K |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $28M | $35M | $42M | $19M | $18M | $22M | $26M | $24M | $23M | $31M | $19M | $16M | $19M | $20M | $735.2K | |
| Short-term Investments | $89M | $66M | $72M | $54M | $15M | $32M | $45M | $41M | $41M | $52M | $57M | $89M | $101M | $108M | $64M | · | |
| Receivables | $51.0K | $84.0K | $95.0K | $52.0K | $83.0K | $89.0K | $92.0K | $115.0K | $80.0K | $67.0K | $99.0K | $86.0K | $171.0K | $76.0K | $96.0K | · | |
| Inventory | $250.0K | $277.0K | $310.0K | $365.0K | $185.0K | $135.0K | $173.0K | $234.0K | $70.0K | $115.0K | $146.0K | $137.0K | $178.0K | $232.0K | $276.0K | · | |
| Prepaid Expense | $977.0K | $1M | $994.0K | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $533.0K | $137.3K | |
| Current Assets | $111M | $96M | $108M | $98M | $36M | $52M | $69M | $69M | $66M | $76M | $89M | $110M | $120M | $130M | $85M | $872.6K | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $993.0K | $921.0K | $849.0K | $778.0K | · | |
| Total Assets | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Accounts Payable | $6M | $6M | $6M | $8M | $5M | $6M | $5M | $5M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $281.6K | |
| Accrued Liabilities | $7M | $7M | $10M | $7M | $7M | $5M | $6M | $7M | $4M | $4M | $5M | $4M | $4M | $3M | $5M | $1M | |
| Current Liabilities | $13M | $14M | $17M | $21M | $17M | $15M | $16M | $16M | $15M | $10M | $11M | $21M | $12M | $12M | $19M | $1M | |
| Capital Leases | $520.0K | $730.0K | $936.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | · | |
| Deferred Tax | · | · | $393.0K | · | · | · | $561.0K | · | · | · | $508.0K | · | · | · | $637.0K | · | |
| Other Non-current Liabilities | $397.0K | $367.0K | $308.0K | $248.0K | $189.0K | $99.0K | $40.0K | · | · | · | · | $266.0K | $213.0K | $249.0K | $196.0K | · | |
| Total Liabilities | $86M | $50M | $51M | $61M | $43M | $42M | $43M | $29M | $28M | $25M | $27M | $37M | $36M | $37M | $43M | $7M | |
| Long-term Debt | · | $15M | $15M | $15M | $15M | $15M | · | · | · | · | · | $10M | $10M | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | $445 | |
| Paid-in Capital | $426M | $424M | $416M | $413M | $348M | $345M | $343M | $340M | $322M | $320M | $317M | $316M | $312M | $310M | $252M | · | |
| Retained Earnings | $-407M | $-383M | $-363M | $-369M | $-348M | $-329M | $-310M | $-294M | $-278M | $-262M | $-249M | $-236M | $-223M | $-211M | $-200M | $-6M | |
| AOCI | $-81.0K | $-40.0K | $60.0K | $45.0K | $16.0K | $37.0K | $52.0K | $98.0K | $-23.0K | $-8.0K | $-10.0K | $-77.0K | $-96.0K | $-35.0K | $-8.0K | · | |
| Stockholders' Equity | $19M | $41M | $54M | $44M | $295.0K | $17M | $33M | $46M | $44M | $57M | $68M | $80M | $89M | $100M | $53M | $-6M | |
| Liabilities + Equity | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Shares Outstanding | 60,105,049 | 58,630,715 | 57,032,963 | 56,464,731 | 38,643,553 | 38,312,512 | 38,194,442 | 37,942,905 | 35,824,571 | 35,784,997 | 35,777,412 | 35,743,972 | 35,743,007 | 31,741,147 | 20,187,850 | 4,450,000 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96.0K | $90.0K | $82.0K | $81.0K | $81.0K | $83.0K | $84.0K | $76.0K | $74.0K | $74.0K | $72.0K | $71.0K | $73.0K | $71.0K | $70.0K | $54.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $919.0K | $4M | $2M | $1M | $863.0K | $2M | |
| Other Non-cash | · | $-4M | · | · | · | $-909.0K | · | · | · | $-2M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-19M | $-22M | $-2M | $-15M | $-16M | $-17M | $-14M | $-14M | $-10M | $-13M | $-11M | $-10M | $-10M | $-14M | $-9M | $-20M | |
| CapEx | $254.0K | $184.0K | $33.0K | $310.0K | $34.0K | $112.0K | $106.0K | $68.0K | $107.0K | $8.0K | $-3.0K | $19.0K | $27.0K | $35.0K | $54.0K | $224.0K | |
| Investing Cash Flow | $-23M | $10M | $-18M | $-39M | $16M | $13M | $-4M | $557.0K | $10M | $6M | $33M | $13M | $8M | $-44M | $-63M | $-224.0K | |
| Financing Cash Flow | $35M | $6M | $13M | $76M | $-428.0K | $-296.0K | $14M | $15M | $171.0K | $18.0K | $-11M | $4.0K | $86.0K | $57M | $-5M | $-2M | |
| Net Change in Cash | $-8M | $-6M | $-7M | $23M | $401.0K | $-4M | $-3M | $2M | $389.0K | $-7M | $11M | $3M | $-2M | $-1M | $-77M | $88M | |
| Free Cash Flow | · | $-22M | · | · | · | $-17M | · | · | · | $-13M | · | · | · | $-14M | · | · |
Rentowność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -25404.5% | -20069.1% | · | -2359.2% | -2311.8% | -2179.8% | · | -1655.7% | -2167.0% | -2326.3% | · | -3466.3% | -1416.0% | -991.8% | · | · | |
| Net Margin | -26994.3% | -18810.0% | · | -2419.1% | -2316.2% | -2160.7% | · | -1562.9% | -2054.0% | -2171.5% | · | -3178.0% | -1316.5% | -939.9% | · | · | |
| EBITDA Margin | -25404.5% | -19987.3% | · | -2359.2% | -2311.8% | -2170.3% | · | -1655.7% | -2167.0% | -2314.3% | · | -3466.3% | -1416.0% | -985.7% | · | · | |
| ROA | -30.0% | -25.9% | · | -23.1% | -33.6% | -26.5% | · | -16.1% | -16.1% | -12.3% | · | -14.4% | -8.4% | -7.3% | · | -0.59% | |
| ROE | -242.2% | -71.3% | · | -46.3% | -87.2% | -50.7% | · | -24.5% | -23.9% | -17.2% | · | -36.2% | -28.6% | -22.9% | · | 13.8% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 7.0 | · | 4.7 | 2.1 | 3.4 | · | 4.2 | 4.6 | 7.3 | · | 5.1 | 10.1 | 10.8 | · | 0.6 | |
| Quick Ratio | 8.2 | 6.9 | · | 4.6 | 2.0 | 3.2 | · | 4.1 | 4.5 | 7.2 | · | 5.1 | 9.9 | 10.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -32.9 | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.1 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.2 | · | 0.6 | 0.6 | 0.4 | · | · | |
| Receivables Turnover | 1.3 | 1.3 | · | 10.3 | 10.3 | 11.1 | · | 9.8 | 6.2 | 8.7 | · | 9.7 | 10.7 | 30.6 | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | · | $4M | $3M | $3M | · | $3M | $3M | $3M | · | $4M | $4M | $4M | · | · | |
| Net Income TTM | $-85M | $-80M | · | $-74M | $-70M | $-64M | · | $-58M | $-55M | $-50M | · | $-47M | $-41M | $-35M | · | $-24M | |
| Market Cap | $259M | $249M | · | $140M | $104M | $164M | · | $195M | $292M | $189M | · | $312M | $250M | $621M | · | $44M | |
| P/E | -2.7 | -2.5 | · | -1.4 | -1.4 | -2.5 | · | -3.2 | -5.2 | -3.5 | · | -5.3 | -3.4 | -8.5 | · | -5.2 | |
| P/S | 136.9 | 93.2 | · | 39.4 | 29.9 | 50.4 | · | 69.6 | 106.9 | 60.5 | · | 85.1 | 68.7 | 172.8 | · | · | |
| P/B | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | -7.3 | |
| P / Tangible Book | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | · | |
| P / Cash Flow | · | -11.2 | · | · | · | -9.9 | · | · | · | -14.4 | · | · | · | -43.2 | · | · | |
| P / FCF | · | -11.1 | · | · | · | -9.8 | · | · | · | -14.4 | · | · | · | -43.1 | · | · | |
| Earnings Yield | -37.3% | -40.5% | · | -72.6% | -69.0% | -40.4% | · | -31.5% | -19.1% | -28.6% | · | -18.8% | -29.0% | -11.8% | · | -19.2% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $33M | $3M | $3M | $4M | — |
| Marża Operacyjna % | -154.7% | -2437.5% | -1866.2% | — | — |
| Zysk netto | $-53M | $-61M | $-49M | $-34M | $-378.8K |
| Rozwodniony EPS | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 6.4 | 4.3 | 8.0 | 0.2 | 10.9 |
| Wskaźnik Szybkości | 6.4 | 4.1 | 7.8 | 0.1 | 10.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-49M | $-51M | $-46M | — | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 86 emitentów · $108.0M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 29 (+13 vs poprzedni kw.) | 13 (0 vs poprzedni kw.) | 17 (-6 vs poprzedni kw.) | 17 (+2 vs poprzedni kw.) | +3.9M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $41 234 412 | 9 556 063 | 38,19% | Akcje |
| PERCEPTIVE ADVISORS LLC | $21 738 564 | 5 037 906 | 20,13% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $8 728 883 | 2 022 916 | 8,08% | Akcje |
| VANGUARD GROUP INC | $5 688 272 | 1 370 668 | 5,27% | Akcje |
| Alyeska Investment Group, L.P. | $4 315 000 | 1 000 000 | 4,00% | Akcje |
| Propel Bio Management, LLC | $3 869 265 | 896 701 | 3,58% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $3 696 819 | 856 460 | 3,42% | Akcje |
| STATE STREET CORP | $2 226 756 | 516 050 | 2,06% | Akcje |
| RICE HALL JAMES & ASSOCIATES, LLC | $1 829 560 | 424 000 | 1,69% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 508 282 | 349 544 | 1,40% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 261 072 | 292 253 | 1,17% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 186 508 | 274 973 | 1,10% | Akcje |
| Knott David M Jr | $1 094 504 | 253 651 | 1,01% | Akcje |
| Flat Footed LLC | $1 084 670 | 251 372 | 1,00% | Akcje |
| Simplify Asset Management Inc. | $946 655 | 219 387 | 0,88% | Akcje |
| DAFNA Capital Management LLC | $547 319 | 126 841 | 0,51% | Akcje |
| AMH Equity Ltd | $411 680 | 166 000 | 0,38% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $388 350 | 90 000 | 0,36% | Akcje |
| IFP Advisors, Inc | $386 659 | 89 608 | 0,36% | Akcje |
| Daytona Street Capital LLC | $379 336 | 96 398 | 0,35% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347 789 | 80 600 | 0,32% | Akcje |
| GOLDMAN SACHS GROUP INC | $323 875 | 75 058 | 0,30% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $283 944 | 65 804 | 0,26% | Akcje |
| CITADEL ADVISORS LLC | $242 464 | 56 191 | 0,22% | Akcje |
| Nuveen, LLC | $224 889 | 52 118 | 0,21% | Akcje |
| Holos Integrated Wealth LLC | $204 316 | 51 595 | 0,19% | Akcje |
| Cubist Systematic Strategies, LLC | $193 172 | 77 892 | 0,18% | Akcje |
| NewEdge Advisors, LLC | $190 218 | 44 083 | 0,18% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $187 642 | 43 486 | 0,17% | Akcje |
| XTX Topco Ltd | $167 482 | 38 814 | 0,16% | Akcje |
| WELLS FARGO & COMPANY/MN | $156 876 | 36 356 | 0,15% | Akcje |
| HighTower Advisors, LLC | $152 643 | 35 375 | 0,14% | Akcje |
| LASRY MARC | $150 955 | 60 869 | 0,14% | Akcje |
| Affinity Asset Advisors, LLC | $144 121 | 33 400 | 0,13% | Akcje |
| RHUMBLINE ADVISERS | $137 813 | 31 940 | 0,13% | Akcje |
| ALGERT GLOBAL LLC | $122 917 | 28 486 | 0,11% | Akcje |
| Meramec Financial Planners, LLC | $114 600 | 30 000 | 0,11% | Akcje |
| TWO SIGMA ADVISERS, LP | $112 465 | 27 100 | 0,10% | Akcje |
| AXQ CAPITAL, LP | $109 808 | 25 448 | 0,10% | Akcje |
| MetLife Investment Management, LLC | $103 534 | 23 994 | 0,10% | Akcje |
| BANK OF AMERICA CORP /DE/ | $102 792 | 23 822 | 0,10% | Akcje |
| Bank of New York Mellon Corp | $99 413 | 23 039 | 0,09% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $97 359 | 22 563 | 0,09% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $91 047 | 21 100 | 0,08% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $88 026 | 20 400 | 0,08% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $79 189 | 18 352 | 0,07% | Akcje |
| CITIGROUP INC | $77 087 | 17 865 | 0,07% | Akcje |
| CITADEL ADVISORS LLC | $75 944 | 17 600 | 0,07% | Opcja sprzedaży |
| UBS Group AG | $75 884 | 17 586 | 0,07% | Akcje |
| Invesco Ltd. | $68 578 | 15 893 | 0,06% | Akcje |
| JANE STREET GROUP, LLC | $66 278 | 15 360 | 0,06% | Akcje |
| Vanguard Global Advisers, LLC | $60 186 | 13 948 | 0,06% | Akcje |
| ABLE Financial Group, LLC | $57 830 | 13 402 | 0,05% | Akcje |
| Sargent Investment Group, LLC | $56 613 | 13 120 | 0,05% | Akcje |
| Frec Markets, Inc. | $56 302 | 13 048 | 0,05% | Akcje |
| CITADEL ADVISORS LLC | $52 212 | 12 100 | 0,05% | Opcja kupna |
| Police & Firemen's Retirement System of New Jersey | $50 723 | 11 755 | 0,05% | Akcje |
| BARCLAYS PLC | $50 115 | 11 614 | 0,05% | Akcje |
| JANE STREET GROUP, LLC | $49 191 | 11 400 | 0,05% | Opcja sprzedaży |
| Garden State Investment Advisory Services LLC | $45 575 | 10 562 | 0,04% | Akcje |
| BlackRock, Inc. | $45 191 | 10 473 | 0,04% | Akcje |
| MORGAN STANLEY | $42 805 | 9 920 | 0,04% | Akcje |
| Nuveen Asset Management, LLC | $41 160 | 10 290 | 0,04% | Akcje |
| China Universal Asset Management Co., Ltd. | $41 122 | 9 530 | 0,04% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $35 443 | 8 214 | 0,03% | Akcje |
| NORTHERN TRUST CORP | $27 163 | 6 295 | 0,03% | Akcje |
| Point72 Asia (Singapore) Pte. Ltd. | $23 178 | 9 346 | 0,02% | Akcje |
| JPMORGAN CHASE & CO | $20 701 | 4 358 | 0,02% | Akcje |
| Legal & General Group Plc | $16 932 | 3 924 | 0,02% | Akcje |
| Ameritas Investment Partners, Inc. | $15 607 | 3 617 | 0,01% | Akcje |
| Tower Research Capital LLC (TRC) | $15 538 | 3 601 | 0,01% | Akcje |
| Russell Investments Group, Ltd. | $13 751 | 3 187 | 0,01% | Akcje |
| Mirae Asset Global Investments Co., Ltd. | $11 556 | 2 678 | 0,01% | Akcje |
| SIMPLEX TRADING, LLC | $11 063 | 2 564 | 0,01% | Akcje |
| AdvisorNet Financial, Inc | $7 318 | 1 696 | 0,01% | Akcje |
| ROYAL BANK OF CANADA | $6 000 | 1 411 | 0,01% | Akcje |
| GF FUND MANAGEMENT CO. LTD. | $5 062 | 1 173 | 0,00% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $3 765 | 888 | 0,00% | Akcje |
| DEUTSCHE BANK AG\ | $3 387 | 784 | 0,00% | Akcje |
| FMR LLC | $682 | 158 | 0,00% | Akcje |
| Point72 (DIFC) Ltd | $675 | 272 | 0,00% | Akcje |
| Sterling Capital Management LLC | $604 | 140 | 0,00% | Akcje |
| Optiver Holding B.V. | $173 | 40 | 0,00% | Akcje |
| PRICE T ROWE ASSOCIATES INC /MD/ | $142 | 32 689 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $65 | 15 | 0,00% | Akcje |
| SBI Securities Co., Ltd. | $26 | 6 | 0,00% | Akcje |
Insiderzy spółki 20 insiderów · 11 dyrektorzy generalni · 7 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David P Hochman | Chief Executive Officer and Chairperson | 10 czerwca 2026 F | 436 199 | 5 | 0 | $116 190 |
| Roderick Wong, M.D. | Chief Executive Officer | 24 stycznia 2023 P | 2 808 512 | 0 | 0 | $0 |
| Andrew Lawrence Taylor | Chief Financial Officer | 10 czerwca 2026 F | 593 065 | 1 | 0 | $5 100 |
| Michael Kaswan | Chief Financial Officer | 26 stycznia 2023 A | 162 574 | 0 | 0 | $0 |
| Darren Sherman | President and Chief Operating Officer | 3 sierpnia 2026 S | 1 154 327 | 1 | 3 | $-175 590 |
| Joshua Aiello | Principal Accounting Officer | 25 marca 2026 F | 18 644 | 0 | 0 | $0 |
| William Reed Little | Executive Vice President, Corporate Development & Strategy | 30 maja 2024 P | 307 859 | 0 | 0 | $0 |
| George Papandreou | General Manager and Senior Vice President, Focal Therapies | 8 maja 2024 A | 42 000 | 0 | 0 | $0 |
| Yuval Mika | General Manager and Chief Technology Officer, Bioelectronic Therapies | 8 maja 2024 A | 158 905 | 0 | 0 | $0 |
| Stephanie A Sirota | VP of Corp Stratege and Comm | 4 sierpnia 2020 P | 20 000 | 0 | 0 | $0 |
| Alice Lee | VP Operations, Sec & Treasurer | 4 sierpnia 2020 P | 10 000 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | Dyrektor | 23 czerwca 2026 A | 66 038 | 0 | 0 | $0 |
| Jason Aryeh | Dyrektor | 23 czerwca 2026 A | 118 118 | 3 | 0 | $39 931 |
| Eric A Rose MD | Dyrektor | 20 czerwca 2024 A | 7 544 | 0 | 0 | $0 |
| Geoffrey Wade Smith | Dyrektor | 20 lipca 2023 A | 20 913 | 0 | 0 | $0 |
| HSAC 2 Holdings, LLC | Posiadacz 10% | 5 sierpnia 2024 J | 1 705 705 | 0 | 0 | $0 |
| Chris Cleary | — | 12 sierpnia 2026 F | 29 153 | 0 | 0 | $0 |
| John Prosper Mack | — | 12 sierpnia 2026 F | 66 544 | 0 | 0 | $0 |
| David Pacitti | — | 12 sierpnia 2026 F | 54 750 | 0 | 0 | $0 |
| Eric S Fain | — | 12 sierpnia 2026 F | 99 630 | 2 | 0 | $97 634 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| RTW Investments, LP, RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., Roderick Wong ×8 zgłoszenia | 29 kwietnia 2026 | 19,20% | Aneks | — | SEC |
| HSAC 2 Holdings, LLC ×3 zgłoszenia | 7 sierpnia 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Geoffrey W. Smith | 7 lutego 2023 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 13 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 133 768 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 3 230 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,01% | 2 089 NS | 31 maja 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 365 204 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 228 058 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 42 916 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,00% | 813 952 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 178 322 NS | 31 maja 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 3 182 NS | 31 maja 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 43 636 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 498 632 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 470 063 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 999 SH | 8 sierpnia 2026 | Dziennie |